The Federation of American Societies for Experimental Biology (FASEB) launches a new service to stream the latest content from in-person FASEB Science Research Conferences.
The Federation of American Societies for Experimental Biology is now accepting applications for the 2024 Howard Garrison Advocacy Fellowship. This opportunity is open to biological and biomedical researchers in all career stages who wish to engage in collaborative exploration of science advocacy and communications.
New research in The FASEB Journal indicates that expression levels of the RPGRIP1L gene might serve as a new prognostic marker for individuals with invasive breast cancer.
The American Society for Pharmacology and Experimental Therapeutics (ASPET) and Elsevier, a global leader in information and analytics, are partnering to publish the Society’s four journals.
The Federation of American Societies for Experimental Biology (FASEB) bestows its highest honor, FASEB Excellence in Science Awards, to three women scientists.
The Federation of American Societies for Experimental Biology (FASEB), the largest coalition of biomedical research associations in the United States, announces a collaboration between FASEB Publications and Dryad.
The Federation of American Societies for Experimental Biology (FASEB) and the Office of Data Science Strategy at the National Institutes of Health (NIH) announced today the recipients of this year’s FASEB DataWorks! Prize.
FASEB launches pilot to change the current culture within the life sciences that negatively affects early-career researchers in historically excluded populations.
The American Society for Pharmacology and Experimental Therapeutics President Namandjé Bumpus will take over as the U.S. Food and Drug Administration’s (FDA) Principal Deputy Commissioner early next year.
FASEB BioArt Awards are presented annually to honor original, visually stunning photographs and videos that effectively communicate an important aspect of 21st century biological research.
The Federation of American Societies for Experimental Biology (FASEB) is pleased to announce the recipients of the fall 2023 CARES (Career Advancement and Research Excellence Support) Awards. CARES helps researchers alleviate financial burdens associated with caregiving, allowing the recipients to pursue professional development opportunities.
During missions into space, astronauts are exposed to high levels of galactic cosmic radiation and weightlessness. Simulation experiments in male rats indicated that these aspects of spaceflight can negatively affect vascular tissues relevant to erectile dysfunction, even after a period of long-term recovery.
The American Society for Pharmacology and Experimental Therapeutics (ASPET) has selected 16 individuals as 2023 ASPET Fellows.
FASEB Conferences On-Demand will ensure that biological and biomedical scientists can stay up to date on the latest advances—wherever and whenever.
Using zebrafish as a model, investigators have determined a suitable combination of chemical compounds in which to store hearts, and potentially other organs, when frozen for extended periods of time before transplantation.
FASEB’s Excellence in Science Awards highlight outstanding achievements by women in the biological and biomedical sciences. The awards are bestowed to female scientists demonstrating not only excellence and innovation in their research fields, but exemplary leadership and mentorship as well.
FASEB named the inaugural Howard Garrison Advocacy Fellows. The fellows will expand their impact as science advocates and help drive change in the research community.
The American Society for Pharmacology and Experimental Therapeutics (ASPET) has automated its Automated Patient-Oriented Problem-Solving (A-POPS) learning tool.
New research published in The FASEB Journal indicates that increasing the expression of a particular gene may help to prevent bone loss associated with postmenopausal osteoporosis.
New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right